BRIEF published on 05/27/2026 at 18:05, 4 months 7 days ago Oxurion Announces a Capital Increase Following the Conversion of Bonds by Atlas Ordinary Shares Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
BRIEF published on 05/27/2026 at 18:05, 4 months 7 days ago Oxurion Announces Voting Rights Update Following Convertible Bonds Conversion Voting Rights Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion Shares
PRESS RELEASE published on 05/27/2026 at 18:00, 4 months 7 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 3 convertible bonds in Oxurion, leading to EUR 75,000 capital increase. Oxurion announces updated information on shares and voting rights Voting Rights Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
BRIEF published on 05/26/2026 at 18:05, 4 months 8 days ago Oxurion announces a reduction in Atlas Special Opportunities II LLC's stake Shares Transparency Atlas Participation Oxurion
BRIEF published on 05/26/2026 at 18:05, 4 months 8 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Atlas Special Opportunities Oxurion Voting Securities Pharmaceutical Subcontractors
PRESS RELEASE published on 05/26/2026 at 18:00, 4 months 8 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC, indicating a significant reduction in their shareholding percentage Transparency Notification European Markets Oxurion NV Shareholding Reduction Pharmaceutical Subcontractors
BRIEF published on 05/05/2026 at 18:05, 4 months 29 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities Transparency Notification Shareholding Atlas Special Opportunities Oxurion Pharmaceutical Subcontractors
BRIEF published on 05/05/2026 at 18:05, 4 months 29 days ago Oxurion Receives a Transparency Notification from Atlas Special Opportunities Transparency Notification Sale Of Shares Atlas Special Opportunities Pharmaceutical Sector Oxurion
PRESS RELEASE published on 05/05/2026 at 18:00, 4 months 29 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding the holding of shares. Forward-looking statements and risks mentioned Forward-looking Statements Transparency Notification Risk Factors Oxurion NV Pharmaceutical Subcontractors
BRIEF published on 04/30/2026 at 18:35, 5 months 3 days ago Oxurion Releases 2025 Annual Report and Convenes Shareholders' Meeting Shareholders' Meeting Annual Report Oxurion Financial Year 2025 Pharmaceutical Outsourcing
Published on 10/03/2026 at 02:35, 21 hours 20 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 10 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 10 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 10 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 8 hours 10 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 3 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 4 hours ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 5 hours ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 1 day 6 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/01/2026 at 19:00, 2 days 4 hours ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 5 hours ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 5 hours ago Covivio - Information on total number of voting rights and share capital
